• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CASI Pharmaceuticals Inc

+ Add to Watchlist


0.935 EUR 0.022 2.41%

As of 15:17:33 ET on 12/23/2014.

Snapshot for CASI Pharmaceuticals Inc (ENMN)

Open: 0.956 Day's Range: 0.921 - 1.026 Volume: 1,000
Previous Close: 0.913 52wk Range: 0.913 - 1.617 1-Yr Rtn: -19.74%

Stock Chart for ENMN

No chart data available.
  • ENMN:GR 0.955
  • 1D
  • 1M
  • 1Y
Interactive ENMN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ENMN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 30.34
Shares Outstanding (M) 32.45
30 Day Average Volume 122
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ENMN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ENMN

CASI Pharmaceuticals Inc. researches and develops biopharmaceutical products that focus on the role of blood and blood vessels in health and disease. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. Therapeutics currently being researched include Endostatin and Angiostatin.

He Wei-WuChairmanKen K RenChief Executive Officer
Cynthia Wong HuVP/COO/Secy/General CounselSara B CapitelliVP:Finance
More Company Profile & Key Executives for ENMN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil